ARTICLE | Clinical News
CAT-2054: Phase IIa data
June 27, 2016 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase IIa trial in 153 patients with hypercholesterolemia showed that oral CAT-2054 plus atorvastatin missed the primary endpoint of reducing LDL-C from baselin...